Anti-integrin monoclonal antibodies - PubMed (original) (raw)
Review
Anti-integrin monoclonal antibodies
Adam Byron et al. J Cell Sci. 2009.
No abstract available
Figures
Figure 1
Similar articles
- Epitopes in α8β1 and other RGD-binding integrins delineate classes of integrin-blocking antibodies and major binding loops in α subunits.
Nishimichi N, Kawashima N, Yokosaki Y. Nishimichi N, et al. Sci Rep. 2015 Sep 9;5:13756. doi: 10.1038/srep13756. Sci Rep. 2015. PMID: 26349930 Free PMC article. - T-cell receptor-based immunointervention in autoimmune diseases. Therapeutic use of monoclonal antibodies.
Chatenoud L, Bach JF. Chatenoud L, et al. Immunol Ser. 1993;59:101-16. Immunol Ser. 1993. PMID: 7681694 Review. No abstract available. - Identification of a novel anti-integrin monoclonal antibody that recognises a ligand-induced binding site epitope on the beta 1 subunit.
Mould AP, Garratt AN, Askari JA, Akiyama SK, Humphries MJ. Mould AP, et al. FEBS Lett. 1995 Apr 17;363(1-2):118-22. doi: 10.1016/0014-5793(95)00301-o. FEBS Lett. 1995. PMID: 7537221 - Identification, characterization, and epitope mapping of human monoclonal antibody J19 that specifically recognizes activated integrin α4β7.
Qi J, Zhang K, Zhang Q, Sun Y, Fu T, Li G, Chen J. Qi J, et al. J Biol Chem. 2012 May 4;287(19):15749-59. doi: 10.1074/jbc.M112.341263. Epub 2012 Mar 14. J Biol Chem. 2012. PMID: 22418441 Free PMC article. - The pathophysiologic role of alpha 4 integrins in vivo.
Lobb RR, Hemler ME. Lobb RR, et al. J Clin Invest. 1994 Nov;94(5):1722-8. doi: 10.1172/JCI117519. J Clin Invest. 1994. PMID: 7525645 Free PMC article. Review. No abstract available.
Cited by
- Strengthening E-cadherin adhesion via antibody-mediated binding stabilization.
Xie B, Xu S, Schecterson L, Gumbiner BM, Sivasankar S. Xie B, et al. Structure. 2024 Feb 1;32(2):217-227.e3. doi: 10.1016/j.str.2023.11.002. Epub 2023 Dec 4. Structure. 2024. PMID: 38052206 - Defined extracellular matrix compositions support stiffness-insensitive cell spreading and adhesion signaling.
Conway JRW, Isomursu A, Follain G, Härmä V, Jou-Ollé E, Pasquier N, Välimäki EPO, Rantala JK, Ivaska J. Conway JRW, et al. Proc Natl Acad Sci U S A. 2023 Oct 24;120(43):e2304288120. doi: 10.1073/pnas.2304288120. Epub 2023 Oct 16. Proc Natl Acad Sci U S A. 2023. PMID: 37844244 Free PMC article. - Identification and Characterization of the Wilms Tumor Cancer Stem Cell.
Petrosyan A, Villani V, Aguiari P, Thornton ME, Wang Y, Rajewski A, Zhou S, Cravedi P, Grubbs BH, De Filippo RE, Sedrakyan S, Lemley KV, Csete M, Da Sacco S, Perin L. Petrosyan A, et al. Adv Sci (Weinh). 2023 Jul;10(20):e2206787. doi: 10.1002/advs.202206787. Epub 2023 Apr 28. Adv Sci (Weinh). 2023. PMID: 37114795 Free PMC article. - Application of a Magnetic Platform in α6 Integrin-Positive iPSC-TM Purification.
Feng P, Wang W, Xu W, Cao Q, Zhu W. Feng P, et al. Bioengineering (Basel). 2023 Mar 25;10(4):410. doi: 10.3390/bioengineering10040410. Bioengineering (Basel). 2023. PMID: 37106597 Free PMC article. - Targeting integrin pathways: mechanisms and advances in therapy.
Pang X, He X, Qiu Z, Zhang H, Xie R, Liu Z, Gu Y, Zhao N, Xiang Q, Cui Y. Pang X, et al. Signal Transduct Target Ther. 2023 Jan 2;8(1):1. doi: 10.1038/s41392-022-01259-6. Signal Transduct Target Ther. 2023. PMID: 36588107 Free PMC article. Review.
References
- Alonso JL, Essafi M, Xiong J-P, Stehle T, Arnaout MA. Does the integrin αA domain act as a ligand for its βA domain? Curr. Biol. 2002;12:R340–R342. - PubMed
- Arnaout MA, Mahalingam B, Xiong J-P. Integrin structure, allostery, and bidirectional signaling. Annu. Rev. Cell Dev. Biol. 2005;21:381–410. - PubMed
- Humphries MJ. Integrin structure. Biochem. Soc. Trans. 2000;28:311–339. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 045225/WT_/Wellcome Trust/United Kingdom
- 092015/WT_/Wellcome Trust/United Kingdom
- 074941/WT_/Wellcome Trust/United Kingdom
- 075796/WT_/Wellcome Trust/United Kingdom
- WT_/Wellcome Trust/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources